XERIS BIOPHARMA HOLDINGS INC

Ticker: XERS CUSIP: 98422E103 Class: Common Stock

RHUMBLINE ADVISERS's Holding History (CIK: 0001115418)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 189,567 Value ($000) $1,488 Avg Close $7.87 Range $6.47 - $10.08
Q3 2025
Shares 213,744 Value ($000) $1,740 Avg Close $6.64 Range $4.52 - $8.35
Q2 2025
Shares 215,691 Value ($000) $1,007 Avg Close $4.58 Range $3.81 - $5.50
Q1 2025
Shares 192,281 Value ($000) $1,056 Avg Close $4.04 Range $3.14 - $6.07
Q4 2024
Shares 180,964 Value ($000) $613 Avg Close $3.22 Range $2.69 - $3.87
Q3 2024
Shares 173,556 Value ($000) $495 Avg Close $2.57 Range $2.03 - $3.04
Q2 2024
Shares 189,970 Value ($000) $427 Avg Close $2.02 Range $1.69 - $2.51
Q1 2024
Shares 177,638 Value ($000) $393 Avg Close $2.59 Range $2.00 - $3.26
Q4 2023
Shares 171,292 Value ($000) $403 Avg Close $1.85 Range $1.46 - $2.44
Q3 2023
Shares 173,808 Value ($000) $323 Avg Close $2.29 Range $1.73 - $2.78
Q2 2023
Shares 173,889 Value ($000) $456 Avg Close $2.55 Range $1.64 - $3.07
Q1 2023
Shares 172,851 Value ($000) $0 Avg Close $1.25 Range $0.97 - $1.70
Q4 2022
Shares 165,861 Value ($000) $0 Avg Close $1.41 Range $1.14 - $1.70
Q3 2022
Shares 162,716 Value ($000) $254 Avg Close $1.65 Range $1.36 - $1.99
Q2 2022
Shares 151,614 Value ($000) $233 Avg Close $2.11 Range $1.25 - $2.72